A single-center retrospective study of factors related to the effects of intravenous glucocorticoid therapy in moderate-to-severe and active thyroid-associated ophthalmopathy

VARIABLES AFFECTING THE LONG-TERM OUTCOME OF GRAVES ORBITOPATHY FOLLOWING HIGH-DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY

(2016) Marenza Leo et al.   Endocrine Practice

Smoking was associated with poor response to intravenous steroids therapy in Graves’ ophthalmopathy

(2015) Lijing Xing et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Current trends in the management of thyroid eye disease

(2015) Rohini Rao et al.   CURRENT OPINION IN OPHTHALMOLOGY

Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy

(2015) Eleonora Sisti et al.   THYROID

A Prospective, Randomized Trial of Intravenous Glucocorticoids Therapy With Different Protocols for Patients With Graves' Ophthalmopathy

(2014) Wei Zhu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Intravenous Glucocorticoids for Graves' Orbitopathy: Efficacy and Morbidity

(2011) S. Zang et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO

(2008) Luigi Bartalena et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY